Showing 1 - 7 results of 7 for search 'Natalia Vallianou', query time: 0.04s
Refine Results
-
1
-
2
Mycobiome and Cancer: What Is the Evidence? by Natalia Vallianou, Dimitris Kounatidis, Gerasimos Socrates Christodoulatos, Fotis Panagopoulos, Irene Karampela, Maria Dalamaga
Published 2021-06-01
Article -
3
-
4
Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives by Natalia Vallianou, Gerasimos Socrates Christodoulatos, Irene Karampela, Dimitrios Tsilingiris, Faidon Magkos, Theodora Stratigou, Dimitris Kounatidis, Maria Dalamaga
Published 2021-12-01
Article -
5
SGLT-2 Inhibitors and the Inflammasome: What’s Next in the 21st Century? by Dimitris Kounatidis, Natalia Vallianou, Angelos Evangelopoulos, Ioannis Vlahodimitris, Eugenia Grivakou, Evangelia Kotsi, Krystalia Dimitriou, Alexandros Skourtis, Iordanis Mourouzis
Published 2023-05-01
Article -
6
Circulating Chemerin and Its Kinetics May Be a Useful Diagnostic and Prognostic Biomarker in Critically Ill Patients with Sepsis: A Prospective Study by Irene Karampela, Gerasimos Socrates Christodoulatos, Natalia Vallianou, Dimitrios Tsilingiris, Evangelia Chrysanthopoulou, George Skyllas, Georgios Antonakos, Ioanna Marinou, Evaggelos Vogiatzakis, Apostolos Armaganidis, Maria Dalamaga
Published 2022-02-01
Article -
7
Circulating Omentin-1 as a Biomarker at the Intersection of Postmenopausal Breast Cancer Occurrence and Cardiometabolic Risk: An Observational Cross-Sectional Study by Gerasimos Socrates Christodoulatos, Georgios Antonakos, Irene Karampela, Sotiria Psallida, Theodora Stratigou, Natalia Vallianou, Antigoni Lekka, Ioanna Marinou, Evaggelos Vogiatzakis, Styliani Kokoris, Athanasios G. Papavassiliou, Maria Dalamaga
Published 2021-10-01
Article